COMPANY
Mission
History
Board and Management
Scientific Advisory Board
Media Center
Careers
ABOUT FERTILIZATION
Introduction
Interesting Links
IN VIVO DEVELOPMENT
The Anecova Approach
The Anecova Technology
Anecova Benefits
Clinical Results
CONTACT
Address
You are here : Home - In vivo Development - The Anecova Technology
THE ANECOVA TECHNOLOGY

The concept of Anecova, restoring the fertilization and early embryonic development phases back into the physiological environment of the maternal uterus instead of the laboratory incubator, is a simple and elegant idea.

However, in translating the idea into a device, our development team has had to manage a list of constraints related to safety, technical feasibility, ease of use and physical issues:
The Need: A Device:
  • That is able to:
  • Transfer injected ovocytes into the uterine cavity for   fertilization and early development
  • Maintain the embryos in the desired position for the   desired timeframe (preserving them from premature   expulsion into the vagina)
  • Be easily retrieved ensuring the availability of the   embryos for morphological and genetic evaluation
  • Allows ALL bidirectional liquid, ion, protein, nutrient,   growth factor and cellular interactions between the   embryos and the maternal organism
  • That has the following characteristics:
  • Fully biocompatible in terms of the materials used, surface characteristics, form and size
  • Lack of toxicity for embryos known to be among the most fragile cell types
  • A comfortable wear for the patient that feels natural and with no unacceptable side effect
  • Flexible, a-traumatic and yet solid
  • Transparent allowing for a good visualization of the embryos inside but echogenic for visualization during placement
  • A size small enough to allow for autocrine and paracrine effects and at the same time large enough to be easily manipulated both by the gynaecologist and the embryologist.
  • That can be placed using an existing, widely utilized, and perfectly mastered routine procedure, adding only a minor modification and without introducing a new medical technique


The Solution
  • A sophisticated device based on state-of-the-art cell encapsulation technology, standing on more than a decade of research and know-how, made in collaboration with The Laboratoire d’Etude sur la Neurodégénérescence at the Ecole Polytechnique Fédérale de Lausanne (EPFL), one of the few specialized labs having high-level expertise on the subject worldwide
  • A technology combining techniques borrowed from microprocessors, nanotechnology, microfluidics and precision manufacturing
  • Exclusively assembled by hand in state-of-the-art facilities in Switzerland and produced with exceptional craftsmanship